Type 2 Diabetes Trial, Recruiting NCT05888909 Sponsor: Chinese PLA General Hospital Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT05888909
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older, of any gender
  • People who have been diagnosed with type 2 diabetes
  • People who have a complete medical history and full clinical records available
  • People with type 2 diabetes who also have chronic kidney disease and have had a kidney biopsy, where the biopsy results gave a clear diagnosis
  • People who are willing to sign a consent form agreeing to take part in the trial

Who may not be able to join:

  • People whose medical history or clinical records are incomplete
  • People who have a kidney disease that is inherited (passed down through their family)
  • People who currently have a urinary tract infection
  • People who have an autoimmune disease (a condition where the immune system attacks the body's own tissues)
  • People who have a cancer diagnosis where survival is expected to be less than 6 months
  • People who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 010 66935462

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chinese PLA General Hospital
Registry
ClinicalTrials.gov
Start date
1 August 2022
Est. completion
1 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

change in estimated glomerular filtration rate (eGFR) from baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov